Search by Drug Name or NDC
NDC 25021-0468-10 Levothyroxine Sodium 100 ug/5mL Details
Levothyroxine Sodium 100 ug/5mL
Levothyroxine Sodium is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is LEVOTHYROXINE SODIUM ANHYDROUS.
Product Information
| NDC | 25021-0468 |
|---|---|
| Product ID | 25021-468_2662e418-ef9b-40be-abbd-db71401e3c20 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Levothyroxine Sodium |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Levothyroxine Sodium Anhydrous |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | ug/5mL |
| Substance Name | LEVOTHYROXINE SODIUM ANHYDROUS |
| Labeler Name | Sagent Pharmaceuticals |
| Pharmaceutical Class | Thyroxine [CS], l-Thyroxine [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA208749 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 25021-0468-10 (25021046810)
| NDC Package Code | 25021-468-10 |
|---|---|
| Billing NDC | 25021046810 |
| Package | 1 VIAL in 1 CARTON (25021-468-10) / 5 mL in 1 VIAL |
| Marketing Start Date | 2024-01-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |